Sex differences in hypothalamic–pituitary–adrenal axis regulation after chronic unpredictable stress
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Introduction: Exposure to stress, mediated through the hypothalamic–pituitary–adrenal (HPA) axis, elicits sex differences in endocrine, neurological, and behavioral responses. However, the sex‐specific factors that confer resilience or vulnerability to stress and stress‐associated psychiatric disorders remain largely unknown. The evident sex differences in stress‐related disease prevalence suggest the underlying differences in the neurobiological underpinnings of HPA axis regulation. Method: Here, we used a chronic unpredictable stress (CUS) model to investigate the behavioral and biochemical responses of the HPA axis in C57BL/6 mice. Animals were tested in the open field and forced swim test to examine anxiety‐like and depressive‐like behaviors. Plasma corticosterone levels were measured after behavior and CUS, and glucocorticoid receptor (GR) expression and cytosolic and nuclear fractions of binding protein FKBP51 expression were taken to measure function and regulation of the stress response. Results: Our results indicate increased depressive‐like behavior in males and females which correlated with increased corticosterone levels following CUS. However, females displayed more anxiety‐like behaviors with and without CUS. Interestingly, we found trends toward dysregulation of GR protein expression in CUS females, and an increase in the GR inhibitory protein, FKBP51, in the cytosol of CUS males but not females. Conclusion: These results suggest biochemical alterations to the HPA axis regulation which may elicit a glucocorticoid resistance in females after chronic stress and may contribute to the sex‐biased vulnerability to stress‐related psychiatric disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The HPA axis in major depression: classical theories and new developments
Pariante, C. M., & Lightman, S. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.006 · Cited by 2,009 · cited 1×
“…of CRF, hyperactivity of the HPA axis, and an inability of GRs to respond adequately to GCs. Animal and human studies suggest reduced expression and function of GRs may be relevant for the pathogenesis of stress-related psychiatric disorders (de Kloet et al., 2005; Pariante & Lightman, 2008).”
BackgroundWillner, P. (2005) · Neuropsychobiology · doi:10.1159/000087097 · Cited by 1,605 · cited 1×
“Here, we adapted a model of CUS (Willner, 2005) to include a variety of “microstressors,” which vary in duration, intensity, and timing (Table 1).”
MethodNeurobiological and Systemic Effects of Chronic Stress
McEwen, B. S. (2017) · Chronic Stress · doi:10.1177/2470547017692328 · Cited by 1,059
Binder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Pütz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., et al. (2004) · Nature Genetics · doi:10.1038/ng1479 · Cited by 977 · cited 1×
“…increased basal levels of FKBP51 (Lukic et al., 2015; Tatro et al., 2009) and has become an important target for physiological stress regulation and potential new drug target therapies for patients with major depressive disorder (Binder et al., 2004; Kirchheiner et al., 2008; Stamm et al., 2016).”
BackgroundWoodruff, P. G., Boushey, H. A., Dolganov, G. M., Barker, C. S., Yang, Y. H., Donnelly, S., Ellwanger, A., Sidhu, S. S., Dao-Pick, T. P., Pantoja, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707413104 · Cited by 828 · cited 1×
“…and clinical populations of depression, where small traces of GCs can rapidly set off the HPA axis cascade (Denny, Valentine, Reynolds, Smith, & Scammell, 2000; Holownia, Mroz, Kolodziejczyk, Chyczewska, & Braszko, 2009; Westberry, Sadosky, Hubler, Gross, & Scammell, 2006; Woodruff et al., 2007).”
BackgroundSex differences in stress-related psychiatric disorders: neurobiological perspectives
Bangasser, D. A., & Valentino, R. J. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.03.008 · Cited by 737
The organization of the stress system and its dysregulation in depressive illness
Gold, P. W. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.163 · Cited by 654
Wochnik, G. M., Rüegg, J., Abel, G. A., Schmidt, U., Holsboer, F., & Rein, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407498200 · Cited by 638
Basomedial amygdala mediates top-down control of anxiety and fear
Adhikari, A., Lerner, T. N., Finkelstein, J., Pak, S., Jennings, J. H., Davidson, T. J., Ferenczi, E., Gunaydin, L. A., Mirzabekov, J. J., Ye, L., et al. (2015) · Nature · doi:10.1038/nature15698 · Cited by 485 · cited 2×
“The corticolimbic circuitry of the stress response comprised of the amygdala, prefrontal cortex, and hippocampus mediates the emotional reactivity from stressful events, such as fear and anxiety (Adhikari et al., 2015).”
BackgroundBoyle, M. P., Brewer, J. A., Funatsu, M., Wozniak, D. F., Tsien, J. Z., Izumi, Y., & Muglia, L. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406458102 · Cited by 378
The Hsp90‐binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo
Riggs, D. L., Roberts, P. J., Chirillo, S. C., Cheung‐Flynn, J., Prapapanich, V., Ratajczak, T., Gaber, R., Picard, D., & Smith, D. F. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg108 · Cited by 353 · cited 1×
“Several reports have characterized FKBP51 as a strong inhibitor of GR function (Fries, Gassen, Schmidt, & Rein, 2015; Riggs et al., 2003), reducing transcriptional activity, (Wochnik et al., 2005) and delaying nuclear translocation of the receptor.”
BackgroundLee, R. S., Tamashiro, K. L. K., Yang, X., Purcell, R. H., Harvey, A., Willour, V. L., Huo, Y., Rongione, M., Wand, G. S., & Potash, J. B. (2010) · Endocrinology · doi:10.1210/en.2010-0225 · Cited by 275
Stress in adolescence and drugs of abuse in rodent models: role of dopamine, CRF, and HPA axis
Burke, A. R., & Miczek, K. A. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3369-1 · Cited by 207
Aging, stress and the hippocampus
Miller, D. B., & O’Callaghan, J. P. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.002 · Cited by 206
The glucocorticoid receptor: part of the solution or part of the problem?
Pariante, C. M. (2006) · Journal of Psychopharmacology · doi:10.1177/1359786806066063 · Cited by 192 · cited 2×
“Additional evidence suggests impaired HPA axis function may be due to a disruption in number and function of GRs in the hippocampus and hypothalamus (Pariante, 2006).”
BackgroundReynolds, P. D., Ruan, Y., Smith, D. F., & Scammell, J. G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5429 · Cited by 184
Davies, T. H., Ning, Y.-M., & Sánchez, E. R. (2005) · Biochemistry · doi:10.1021/bi048503v · Cited by 180
Novel glucocorticoid receptor coactivator effector mechanisms
Jenkins, B. D., Pullen, C. B., & Darimont, B. D. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00357-x · Cited by 150
Genetic Variants in FKBP5 Affecting Response to Antidepressant Drug Treatment
Kirchheiner, J., Lorch, R., Lebedeva, E., Seeringer, A., Roots, I., Sasse, J., & Brockmöller, J. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.7.841 · Cited by 104 · cited 1×
“…increased basal levels of FKBP51 (Lukic et al., 2015; Tatro et al., 2009) and has become an important target for physiological stress regulation and potential new drug target therapies for patients with major depressive disorder (Binder et al., 2004; Kirchheiner et al., 2008; Stamm et al., 2016).”
BackgroundFKBP51 – a selective modulator of glucocorticoid and androgen sensitivity
Stechschulte, L. A., & Sanchez, E. R. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.04.012 · Cited by 92 · cited 1×
“…the immunophilin FK506binding protein 51 (FKBP51) is a glucocorticoid-induced negative regulator of GR through sequestering the receptor into the cytoplasm and reducing hormone binding affinity (Davies, Ning, & Sánchez, 2005; Reynolds, Ruan, Smith, & Scammell, 1999; Stechschulte & Sanchez, 2011).”
BackgroundWestberry, J. M., Sadosky, P. W., Hubler, T. R., Gross, K. L., & Scammell, J. G. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.03.004 · Cited by 91
HNRC, Tatro, E. T., Everall, I. P., Masliah, E., Hult, B. J., Lucero, G., Chana, G., Soontornniyomkij, V., & Achim, C. L. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9146-6 · Cited by 75 · cited 1×
“It is hypothesized that depressed patients have increased basal levels of FKBP51 (Lukic et al., 2015; Tatro et al., 2009) and has become an important target for physiological stress regulation and potential new drug target therapies for patients with major depressive disorder (Binder et al., 2004;…”
BackgroundHolownia, A., Mroz, R. M., Kolodziejczyk, A., Chyczewska, E., & Braszko, J. J. (2009) · European journal of medical research · doi:10.1186/2047-783x-14-s4-108 · Cited by 20
Cited by
Cellular senescence as a driver of cognitive decline triggered by chronic unpredictable stress
Lin, Y.-F., Wang, L.-Y., Chen, C.-S., Li, C.-C., & Hsiao, Y.-H. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100341 · Cited by 47
Possamai-Della, T., Cararo, J. H., Aguiar-Geraldo, J. M., Peper-Nascimento, J., Zugno, A. I., Fries, G. R., Quevedo, J., & Valvassori, S. S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03348-1 · Cited by 16
Sex Differences in Anxiety and Depression: What Can (and Cannot) Preclinical Studies Tell Us?
Mir, F. R., & Rivarola, M. A. (2022) · Sexes · doi:10.3390/sexes3010012 · Cited by 14
“However, only stressed female mice had reduced levels of hippocampal and hypothalamic glucocorticoid receptor, and only stressed male mice had higher cytoplasmatic levels of the co-chaperone protein, FKBP51, in the cortex, indicating a sex difference in HPA axis regulation [46].”
BackgroundResultInozemtseva, L. S., Yatsenko, K. A., Glazova, N. Y., Kamensky, A. A., Myasoedov, N. F., Levitskaya, N. G., Grivennikov, I. A., & Dolotov, O. V. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177068 · Cited by 5
Metadata
- Authors
- Palumbo, M. C., Dominguez, S., & Dong, H.
- Venue
- Brain and Behavior
- Publisher
- Wiley
- Published
- 2020-03-10
- Volume
- 10
- Issue
- 4
- Pages
- e01586-e01586
- ISSN
- 2157-9032 (ISSN-L)
- 2162-3279
- OpenAlex
- W3011395743
- Cited by
- 37
- References
- 23
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.